Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)UnknownNCT04780685
What this trial is testing

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Who this might be right for
Covid19
Stemedica Cell Technologies, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT04537806
What this trial is testing

Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCOVID-19
Sage Therapeutics 29
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Not applicableStudy completedNCT05531032
What this trial is testing

HRQOL of Life After ECMO Due to COVID-19.

Who this might be right for
ARDSCOVID-19 PneumoniaExtracorporeal Membrane Oxygenation
Medical University of Vienna 44
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Not applicableUnknownNCT05665153
What this trial is testing

Symphony IL-6 Study in Patients at Risk of Severe Sepsis

Who this might be right for
Severe Sepsis
Bluejay Diagnostics, Inc. 200
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableStudy completedNCT05946525
What this trial is testing

Ventilatory Variables in Subjects With Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
Respiratory MechanicsRespiration, ArtificialRespiratory Distress Syndrome
Hospital Donación Francisco Santojanni 110
Early research (Phase 1)Ended earlyNCT05027815
What this trial is testing

Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)

Who this might be right for
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Jeffrey Bluestone 7
Not applicableStudy completedNCT04894214
What this trial is testing

Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiration, Artificial
University Hospital, Antwerp 11
Not applicableLooking for participantsNCT05562505
What this trial is testing

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

Who this might be right for
Mechanical Ventilation ComplicationHypoxemiaAcute Respiratory Distress Syndrome Due to COVID-19+3 more
Australian and New Zealand Intensive Care Research Centre 140
Not applicableStudy completedNCT04922814
What this trial is testing

Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeSedation ComplicationICU Acquired Weakness
Assiut University 40
Not applicableUnknownNCT05697016
What this trial is testing

Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
Respiratory Infection VirusRespiratory Failure
Beijing Tiantan Hospital 238
Testing effectiveness (Phase 2)Ended earlyNCT04771000
What this trial is testing

Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19

Who this might be right for
Covid19Hypoxemia
Noorik Biopharmaceuticals AG 88
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Early research (Phase 1)Study completedNCT04537351
What this trial is testing

The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause

Who this might be right for
Covid19Acute Respiratory Distress Syndrome
Cynata Therapeutics Limited 14
Not applicableStudy completedNCT05910996
What this trial is testing

Prediction of Conversion From Vv-ECMO to Va-ECMO in COVID-19 Patients

Who this might be right for
ARDS Due to Disease Caused by SARS Co-V-2
Kepler University Hospital 99
Testing effectiveness (Phase 2)Study completedNCT04510662
What this trial is testing

Telmisartan in Respiratory Failure Due to COVID-19

Who this might be right for
COVID-19Respiratory InsufficiencyTelmisartan+1 more
Abraham Edgar Gracia-Ramos 66
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Not applicableStudy completedNCT05392062
What this trial is testing

Pathophysiology of Gas Exchange and Time Course Changes in Spontaneously Breathing Patients With Acute Respiratory Failure Due to COVID-19. A Multicenter Prospective Study.

Who this might be right for
Respiratory Insufficiency
CHU de Reims 59
Next Page